Get App Open
In App
Credit Cards
Open App
you are here:

SBI Healthcare Opportunities Fund - Direct Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
Fund House : SBI Mutual Fund
  • NAV
    : ₹ 490.6772 0.99%
    (as on 06th October, 2025)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 91.95% investment in domestic equities of which 28.32% is in Large Cap stocks, 13.24% is in Mid Cap stocks, 6.94% in Small Cap stocks.The fund has 0.07% investment in Debt, of which 0.07% in Government securities.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 03rd October, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 26-Sep-25 10091.60 0.92% - 1.79% 202/227
1 Month 03-Sep-25 9801.00 -1.99% - 1.29% 220/226
3 Month 03-Jul-25 9765.40 -2.35% - 0.28% 190/216
6 Month 03-Apr-25 10313.50 3.14% - 14.39% 205/212
YTD 01-Jan-25 9742.00 -2.58% - 3.37% 156/201
1 Year 03-Oct-24 10263.20 2.63% 2.63% 0.23% 53/182
2 Year 03-Oct-23 15393.70 53.94% 24.03% 20.18% 30/140
3 Year 03-Oct-22 19960.40 99.60% 25.88% 20.44% 20/115
5 Year 01-Oct-20 25121.40 151.21% 20.19% 23.49% 60/90
10 Year 01-Oct-15 31142.40 211.42% 12.01% 15.10% 58/65
Since Inception 02-Jan-13 80712.50 707.12% 17.78% 13.74% 62/195

SIP Returns (NAV as on 03rd October, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 03-Oct-24 12000 12123.27 1.03 % 1.9 %
2 Year 03-Oct-23 24000 27784.74 15.77 % 14.75 %
3 Year 03-Oct-22 36000 50198.8 39.44 % 22.8 %
5 Year 01-Oct-20 60000 100485.3 67.48 % 20.73 %
10 Year 01-Oct-15 120000 315616.68 163.01 % 18.38 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 31st Aug,2025)

Portfolio Turnover Ratio : 14.00%  |   Category average turnover ratio is 154.05%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 91.95% | F&O Holdings : 0.00%| Foreign Equity Holdings : 4.24%| Total : 96.19%
No of Stocks : 31 (Category Avg - 44.44) | Large Cap Investments : 28.32%| Mid Cap Investments : 13.24% | Small Cap Investments : 6.94% | Other : 47.69%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 4305.2 10.86% -0.58% 13.98% (Apr 2025) 10.86% (Aug 2025) 27.00 L 0.00
Divis Laboratories Ltd. Pharmaceuticals 2697.9 6.81% -0.40% 7.78% (Jun 2025) 5.86% (Sep 2024) 4.40 L 0.00
Max Healthcare Institute Ltd. Hospital 2424 6.12% -0.38% 6.96% (Jun 2025) 5.66% (Nov 2024) 21.00 L 0.00
Cipla Ltd. Pharmaceuticals 1907.3 4.81% 0.18% 5.9% (Dec 2024) 4.54% (Oct 2024) 12.00 L 0.00
Lonza Group AG Foreign equity 1680.3 4.24% 0.15% 5% (Feb 2025) 4.09% (Jul 2025) 2.70 L 0.00
- Lupin Ltd. Pharmaceuticals 1591.7 4.02% 0.00% 5.24% (Sep 2024) 4.02% (Jul 2025) 8.40 L 0.00
Torrent Pharmaceuticals Ltd. Pharmaceuticals 1423.9 3.59% 0.62% 3.59% (Aug 2025) 2.58% (May 2025) 4.00 L 80.00 k
Mankind Pharma Ltd. Pharmaceuticals 1384 3.49% -0.08% 4.15% (Dec 2024) 2.96% (Nov 2024) 5.60 L 0.00
Fortis Healthcare Ltd. Hospital 1367.3 3.45% 0.26% 3.45% (Aug 2025) 2.19% (Oct 2024) 15.00 L 0.00
Gland Pharma Ltd. Pharmaceuticals 1310.1 3.31% -0.28% 3.59% (Jul 2025) 2.06% (Apr 2025) 7.00 L 0.00
- indicates change in weight in the portfolio. # indicates a new entry.
No of Debt Holding 1 (Category Avg - 1.04) | Modified Duration 0.00 Years (Category Avg - 0.00)| Yield to Maturity - -- (Category Avg - 0.00%)

Type of Holdings

Security Type
% Weight
Category Average
GOI 0.00% 0.01%
T-Bills 0.07% 0.47%

Investment / Portfolio Grades

Security Type
% Weight
Category Average
Government Backed 0.07% 0.48%
Low Risk 0.00% 0.00%
Moderate Risk 0.00% 0.00%
High Risk 0.00% 0.00%
Very High Risk 0.00% 0.00%
Others 0.00% 0.00%
Name Type of Instrument Weight (%)
TREPS TREPS 4.32%
Net Receivables Net Receivables -0.58%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)

  • Standard Deviation

    Low volatility
    10.98vs12.57
    Category Avg
  • Beta

    Low volatility
    0.83vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.54vs1.01
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.2vs0.18
    Category Avg
  • Jensen's Alpha

    Poor risk adjusted returns
    3.42vs3.66
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Direct Plan - Growth NA 389.09 5.57 26.10 74.02 53.74 37.89
Aditya Birla Sun Life International Equity Fund - Direct Plan - Growth NA 249.75 3.84 11.32 33.40 28.36 19.17
HDFC Defence Fund - Direct Plan - Growth NA 6532.01 7.43 -3.79 29.49 18.49 0.00
Nippon India Japan Equity Fund - Direct Plan - Growth NA 283.56 3.57 12.25 26.77 18.02 19.94
Nippon India US Equity Opportunities Fund - Direct Plan - Growth NA 713.51 2.68 5.83 24.82 17.87 22.91
SBI Banking & Financial Services Fund - Direct Plan - Growth NA 8370.76 4.24 1.47 13.85 15.46 20.92
Franklin Asian Equity Fund - Direct - Growth NA 259.99 6.88 12.22 24.26 14.93 14.72
Motilal Oswal Business Cycle Fund - Direct Plan - Growth NA 1976.19 -1.93 -0.01 15.03 13.15 0.00
DSP Banking & Financial Services Fund - Direct Plan - Growth NA 1331.23 3.88 0.64 12.41 13.15 0.00
ITI Banking and Financial Services Fund - Direct Plan - Growth NA 301.88 4.26 0.34 10.34 12.77 16.21

More Funds from SBI Mutual Fund

Out of 109 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 6 is/are ranked 4 * , 7 is/are ranked 3 * , 8 is/are ranked 2 * , 6 is/are ranked 1 * , and 81 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
SBI Equity Hybrid Fund - Direct Plan - Growth 3 77255.73 2.02 -0.48 10.25 8.85 14.65
SBI Liquid Fund - Direct Plan - Growth 3 63824.39 0.48 1.42 3.05 6.79 7.04
SBI Large Cap Fund - Direct Plan - Growth 3 52420.61 0.81 -1.25 10.48 1.21 15.31
SBI Contra Fund - Direct Plan - Growth 4 46653.99 0.44 -2.41 8.65 -3.07 21.15
SBI Arbitrage Opportunities Fund - Direct Plan - Growth 4 41551.78 0.44 1.44 3.17 7.20 7.69
SBI Savings Fund - Direct Plan - Growth 1 38450.02 0.56 1.52 3.67 7.82 7.63
SBI Focused Fund - Direct Plan - Growth 4 37763.80 1.34 0.91 12.91 8.03 16.41
SBI Balanced Advantage Fund - Direct Plan - Growth NA 36673.43 1.59 -0.64 7.14 4.76 14.88
SBI Small Cap Fund - Direct Plan - Growth 2 35244.91 -0.53 -2.06 11.12 -6.66 15.09
SBI Large & Midcap Fund - Direct Plan - Growth 3 33248.12 0.64 -0.72 12.44 2.69 17.65

Forum

+ See More